Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2011; 17(41): 4581-4589
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4581
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4581
Test | Region (n) | F2-4 (%) | Sens | Spec | PPV (%) | NPV (%) | Accuracy (%) | AUROC |
FS | Asia (253) | 24.9 | 0.90 | 0.60 | 42.9 | 95.0 | 67.6 | 0.83 |
NAR (1802) | 17.4 | 0.86 | 0.61 | 31.9 | 95.4 | 65.5 | 0.82 | |
TE | Asia (33) | 24.2 | 0.88 | 0.92 | 77.8 | 95.8 | 90.9 | 0.92 |
NAR (181) | 19.3 | 0.77 | 0.87 | 58.7 | 94.1 | 85.1 | 0.87 | |
FS + TE | Asia (33) | 24.2 | 0.88 | 1.00 | 100.0 | 96.2 | 97.0 | 0.97 |
NAR (176) | 19.3 | 0.91 | 0.68 | 40.8 | 97.0 | 72.7 | 0.88 |
- Citation: Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Häussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE™ and FibroScan® in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol 2011; 17(41): 4581-4589
- URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4581.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i41.4581